By unraveling the intricate interplay between p53 mutations and the key characteristics of cancer stem cells, such as quiescence, stemness maintenance, and treatment resistance, we can establish new theoretical frameworks and experimental insights for designing innovative therapeutic strategies targeting cancer stem cells (Figure 6). This evidence concerns the gene TP53 and cancer.